Stay updated on Trametinib and Pembrolizumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Trametinib and Pembrolizumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Trametinib and Pembrolizumab in NSCLC Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Locations section now lists Connecticut and Texas as study sites, with the revision updated to v3.3.3. The HHS Vulnerability Disclosure link appears removed.
    Difference
    0.3%
    Check dated 2025-12-23T21:40:27.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    33 days ago
    Change Detected
    Summary
    A new revision label v3.3.2 is shown, and the previous v3.2.0 label is removed.
    Difference
    0.1%
    Check dated 2025-11-25T11:49:10.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    Removed the government funding lapse notice that warned users about potential outdated information and possible processing delays, along with the NIH/OPM operating status links. This does not alter the study details, eligibility criteria, or other substantive content on the page.
    Difference
    0.4%
    Check dated 2025-11-18T07:15:18.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    No significant additions or deletions were detected; the content appears unchanged between the two screenshots. Any minor differences are likely routine timestamp updates that do not affect the page's purpose.
    Difference
    0.4%
    Check dated 2025-11-03T21:24:22.000Z thumbnail image
  6. Check
    83 days ago
    Change Detected
    Summary
    Major changes include a user-visible status notice about government funding and NIH Clinical Center operations, and a version update from v3.1.0 to v3.2.0.
    Difference
    2%
    Check dated 2025-10-06T06:58:49.000Z thumbnail image
  7. Check
    90 days ago
    Change Detected
    Summary
    Version updated from v3.0.2 to v3.1.0; no other content changes detected.
    Difference
    0.1%
    Check dated 2025-09-29T03:39:09.000Z thumbnail image

Stay in the know with updates to Trametinib and Pembrolizumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Trametinib and Pembrolizumab in NSCLC Clinical Trial page.